Familial hyperlipoproteinemia
Neurogenic bladder
Rapid Plasma Reagin (RPR), CSF
Enterobiasis
CD4/CD8 Lymphocyte Ratio, Bronchoalvolar lavage
Hepatitis E Virus (HEV) Antibody, IgM
Dermatomyositis
Dopamine beta-hydroxylase (DBH) Genetic Variations
Mucopolysaccharidosis type IH
Colorado Tick Fever Virus Ab, IFA
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Methodology
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...